Home › Funds › HIMENSION CAPITAL (SINGAPORE) PTE. LTD. › NTLA
HIMENSION CAPITAL (SINGAPORE) PTE. LTD. position in NTLA
INTELLIA THERAPEUTICS INC · Health Care
HIMENSION CAPITAL (SINGAPORE) PTE. LTD. reported holding 363,585 shares of NTLA (INTELLIA THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$4.4M, representing 0.30% of its reported portfolio and ranking #33 among its reported holdings. HIMENSION CAPITAL (SINGAPORE) PTE. LTD. has disclosed NTLA holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How HIMENSION CAPITAL (SINGAPORE) PTE. LTD.'s NTLA position evolved
HIMENSION CAPITAL (SINGAPORE) PTE. LTD. first disclosed a stake in NTLA in Q3 2023 at 1,145,091 shares (US$36.2M). Across 13 filings, HIMENSION CAPITAL (SINGAPORE) PTE. LTD. increased the stake 3 time(s), trimmed it 7 time(s) and left it unchanged 2 time(s). The most recent filing (Q3 2026) shows 363,585 shares valued at US$4.4M — an increase of 36,692 shares quarter over quarter.. Notable position changes include a 26% trim in Q1 2026 (shares rose 32% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 1.15M | $36.21M | New |
| Q4 2023 | 1.03M | $31.42M | Reduce |
| Q1 2024 | 1.03M | $28.35M | Hold |
| Q2 2024 | 1.03M | $23.05M | Hold |
| Q3 2024 | 1.08M | $22.11M | Add |
| Q4 2024 | 985.72K | $11.49M | Reduce |
| Q1 2025 | 752.68K | $5.35M | Reduce |
| Q2 2025 | 729.42K | $6.84M | Reduce |
| Q3 2025 | 565.13K | $9.76M | Reduce |
| Q4 2025 | 578.56K | $5.20M | Add |
| Q1 2026 | 429.54K | $5.51M | Reduce |
| Q2 2026 | 326.89K | $5.53M | Reduce |
| Q3 2026 | 363.58K | $4.38M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About NTLA and 13F data
NTLA (INTELLIA THERAPEUTICS INC) is a Health Care company. 34 other funds we track also report a position in NTLA — the largest reported positions include ARK Invest (US$192.1M), RA CAPITAL MANAGEMENT, L.P. (US$76.6M), REGENERON PHARMACEUTICALS, INC. (US$44.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding NTLA
- ARK Invest 15.93M sh · $192.06M · Q3 2026
- RA CAPITAL MANAGEMENT, L.P. 4.53M sh · $76.60M · Q2 2026
- REGENERON PHARMACEUTICALS, INC. 3.70M sh · $44.66M · Q3 2026
- Amova Asset Management Americas, Inc. 3.61M sh · $43.51M · Q3 2026
- Contrarius Group Holdings Ltd 2.43M sh · $29.33M · Q3 2026
- ARMISTICE CAPITAL, LLC 1.50M sh · $25.38M · Q2 2026
- Ghisallo Capital Management LLC 1.20M sh · $20.30M · Q2 2026
More on HIMENSION CAPITAL (SINGAPORE) PTE. LTD.
FAQ
How long has HIMENSION CAPITAL (SINGAPORE) PTE. LTD. held NTLA?
HIMENSION CAPITAL (SINGAPORE) PTE. LTD. has disclosed NTLA holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is HIMENSION CAPITAL (SINGAPORE) PTE. LTD.'s current position in NTLA?
As of Q3 2026, HIMENSION CAPITAL (SINGAPORE) PTE. LTD. holds 363.58K shares of NTLA (INTELLIA THERAPEUTICS INC), valued at $4.38M, representing 0.30% of its reported portfolio and ranking #33.
Has HIMENSION CAPITAL (SINGAPORE) PTE. LTD. been buying or selling NTLA?
In the latest 13F filing (Q3 2026), HIMENSION CAPITAL (SINGAPORE) PTE. LTD. increased its position in NTLA.
Which other funds hold NTLA?
Other major institutional holders of NTLA include ARK Invest, RA CAPITAL MANAGEMENT, L.P., REGENERON PHARMACEUTICALS, INC., among 34 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.